#ExpertAnswers: Rajendra Kumari and Gera Goverse on the Cancer Immunity Cycle
Airdate: Friday, December 2, 2022 Season: 9 Episode: 46
Guests: Gera Goverse, Rajendra Kumari
In this episode of #ExpertAnswers, Dr. Rajendra Kumari and Dr. Gera Goverse from Crown Bioscience answer questions from a recent webinar where they provide an overview of the cancer immunity cycle and present several methods, techniques, and model systems for immuno-oncology research.
To watch the webinar, click here.
Associated Webinar: Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
Similar Podcasts
Industry Insights with Crown Bioscience: Targeting T Cells Within the Cancer Immunity Cycle
Saskia De Man, Marrit Putker, and Pirouz Daftarian from Crown Bioscience discuss the impact of T cell-directed immunotherapy on the cancer-immunity cycle.
#ExpertAnswers: Amy Sheng on Antibody Screening and Discovery
Amy Sheng provides an overview of antibody screening platforms and presents applications and case studies using the Beacon® platform for antibody discovery.
Industry Insights with Crown Bioscience: In Vitro Technologies for Studying the Cancer-Immunity Cycle
Rajendra Kumari and Gera Goverse from Crown Bioscience provide an overview of the cancer-immunity cycle and describe in vivo, in vitro, and ex vivo research tools to study immuno-oncology.
Related Content
Analyzing the Suppressive TME in in Vitro Based Assays
Experts describe suppressive tumor immune microenvironment compartments and patient-derived tissue technologies capable of recapitulating the TME for clinically-relevant studies.
Real-time IntraVital Microscopy (IVM): In Vivo Cellular-level Imaging of Internal Organs in a Live Animal
Join Pilhan Kim, PhD for an in-depth discussion on the All-in-One intravital two-photon and confocal microscopy system.
What’s Next in Preclinical Cancer Immunotherapy Research?
This webinar will include a panel discussion of key topics in the field of cancer immunotherapy, including new and emerging methods, recent publications, and future directions.